Novoimmune

View All

Pharma Business news
Telegenomics nets $23M; Merck acquires Tilos; ADC nabs; Sobi buys Novoimmune’s assets

Telegenomics Company Genome Medical nets USD 23 M Genome Medical, a telegenomics company, having expertise in delivering genome-based medicine has raised USD 23 Million in series B funding.  The proceeds will be used by the company to accelerate the development of its technology and medical services to supp...

Find More